Verona Pharma (VRNA) Insider Trading & Ownership $38.85 +0.76 (+2.00%) (As of 11/20/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Verona Pharma (NASDAQ:VRNA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.80%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$188,928.00Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$5.08 M Get VRNA Insider Trade Alerts Want to know when executives and insiders are buying or selling Verona Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address VRNA Insider Buying and Selling by Quarter Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Verona Pharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/11/2024David ZaccardelliCEOSell2,400$5.00$12,000.00 11/6/2024David R EbsworthDirectorBuy39,360$4.80$188,928.00 11/4/2024David ZaccardelliCEOSell94,144$4.39$413,292.16 11/4/2024Mark W HahnCFOSell80,784$4.39$354,641.76 11/1/2024David ZaccardelliCEOSell46,888$4.38$205,369.44 11/1/2024Mark W HahnCFOSell48,888$4.38$214,129.44 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 10/25/2024David ZaccardelliCEOSell4,800$4.38$21,024.00 10/24/2024Mark W HahnCFOSell141,360$4.38$619,156.80 10/23/2024David ZaccardelliCEOSell16$4.38$70.08 10/21/2024David ZaccardelliCEOSell110,456$4.38$483,797.28 10/21/2024Mark W HahnCFOSell116,696$4.38$511,128.48 10/18/2024David ZaccardelliCEOSell245,784$4.38$1,076,533.92 10/18/2024Mark W HahnCFOSell249,728$4.38$1,093,808.64 5/3/2024Kathleen A RickardInsiderSell36,248$1.96$71,046.08 (Data available from 1/1/2013 forward) VRNA Insider Trading Activity - Frequently Asked Questions Who is on Verona Pharma's Insider Roster? The list of insiders at Verona Pharma includes Claire Poll, David R Ebsworth, David Zaccardelli, Kathleen A Rickard, Lisa Deschamps, Mark W Hahn, Martin Edwards, and Orbimed Advisors Llc. Learn more on insiders at VRNA. What percentage of Verona Pharma stock is owned by insiders? 4.80% of Verona Pharma stock is owned by insiders. Learn more on VRNA's insider holdings. Which Verona Pharma insiders have been buying company stock? The following insiders have purchased VRNA shares in the last 24 months: David R Ebsworth ($505,728.00), and Martin Edwards ($62,074.24). How much insider buying is happening at Verona Pharma? Insiders have purchased a total of 233,096 VRNA shares in the last 24 months for a total of $567,802.24 bought. Which Verona Pharma insiders have been selling company stock? The following insiders have sold VRNA shares in the last 24 months: Claire Poll ($1,352,598.48), David Zaccardelli ($6,354,840.32), Kathleen A Rickard ($875,968.72), Mark W Hahn ($5,607,638.24), and Orbimed Advisors Llc ($95,419,764.96). How much insider selling is happening at Verona Pharma? Insiders have sold a total of 9,240,025 Verona Pharma shares in the last 24 months for a total of $109,610,810.72 sold. Verona Pharma Key ExecutivesDr. David S. Zaccardelli Pharm.D. (Age 60)President, CEO & Executive Director Compensation: $1.27MMr. Mark W. Hahn (Age 61)Chief Financial Officer Compensation: $858.29k5 recent tradesDr. Kathleen A. Rickard M.D. (Age 66)Chief Medical Officer Compensation: $650.83kMr. Andrew Fisher (Age 54)General Counsel Ms. Victoria StewartDirector of CommunicationsMr. Matthew CasbonVP of Sales, Marketing & TrainingMs. Ostra JewellSenior Vice President of Human ResourcesDr. Tara Rheault M.P.H. (Age 48)Ph.D., Chief Development Officer Mr. Christopher MartinChief Commercial OfficerMs. Caroline DiazSenior Vice President of Regulatory Affairs More Insider Trading Tools from MarketBeat Related Companies PCVX Insider Selling CTLT Insider Selling SRPT Insider Selling RVMD Insider Selling ITCI Insider Selling ROIV Insider Selling ELAN Insider Selling CYTK Insider Selling BPMC Insider Selling NUVL Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:VRNA) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verona Pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Verona Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
